Table 2.
mMRC ≥2 | p value | Exacerbation ≥2 year-1 | p value | |
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | |||
Age, per 1-year increase | 1.05 (1.03–1.07) | <0.0001 | 1.00 (0.98–1.02) | 0.98 |
%FEV1, per 1% increase | 0.94 (0.94–0.95) | <0.0001 | 0.96 (0.95–0.97) | <0.0001 |
Sex (females versus males) | 2.02 (1.32–3.09) | 0.0011 | 2.04 (1.25–3.33) | 0.0046 |
Notes: The results indicated that even after adjusting for age and %FEV1, females exhibited significantly higher levels of dyspnea and exacerbation rates compared to males.
Abbreviations: %FEV1, percent predicted forced expiratory volume in 1 s; mMRC, modified medical research council dyspnea scale; OR, odds ratio; CI, confidence interval.